Vasomune Therapeutics Inc., and AnGes Inc., Expand the Scope of the Co-Development …

… back pain. Furthermore, AnGes acquired EmendoBio in December 2020 to expand its capabilities in genome-editing technologies. For more information …
Source: back pain